European Medicines Agency Agency Recalls Pacira Pharmaceuticals, Inc. Drug on Contamination Worries

Published: Aug 27, 2012

The European Medicines Agency said on Friday it had recommended cancer drug DepoCyte be recalled in Europe, where suitable alternative treatments are available, due to sterility concerns at a U.S. plant operated by Pacira Pharmaceuticals. A recent inspection carried out jointly by France and Britain at Pacira's manufacturing site in San Diego identified a number of manufacturing deficiencies related to a lack of adequate sterility assurance in the manufacturing process.

Back to news